Table 4.2.

Individualised treatment using the Li-NBAL 1.0

Patient’s characteristics	Method(s)
Early stage liver failure	PE
Middle stage liver failure	PE + HF, PE+ plasma perfusion
Cholestasis	Bilirubin adsorption or PE+ bilirubin adsorption
Liver failure patients with renal failure	PE + HD, PE + HF, or PE + CHDF
Liver failure patients with hepatic encephalopathy	PE + HP, PE + HF or PE + CHDF
Liver failure patients with water and electrolyte disturbance	PE + HF, or PE + CHDF
Drug and poison-induced liver failure	PE + HF, or PE + HP

PE plasma exchange, HF haemofiltration, HP haemoperfusion, HD haemodialysis, CHDF continuous haemodiafiltration